These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20614853)

  • 1. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice.
    Okuro M; Fujiki N; Kotorii N; Ishimaru Y; Sokoloff P; Nishino S
    Sleep; 2010 Jul; 33(7):930-42. PubMed ID: 20614853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice.
    Fujiki N; Cheng T; Yoshino F; Nishino S
    Exp Neurol; 2009 May; 217(1):46-54. PubMed ID: 19416673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice.
    Sagawa Y; Sato M; Sakai N; Chikahisa S; Chiba S; Maruyama T; Yamamoto J; Nishino S
    Neuropharmacology; 2016 Nov; 110(Pt A):268-276. PubMed ID: 27474349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.
    Lin JS; Dauvilliers Y; Arnulf I; Bastuji H; Anaclet C; Parmentier R; Kocher L; Yanagisawa M; Lehert P; Ligneau X; Perrin D; Robert P; Roux M; Lecomte JM; Schwartz JC
    Neurobiol Dis; 2008 Apr; 30(1):74-83. PubMed ID: 18295497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.
    Guo RX; Anaclet C; Roberts JC; Parmentier R; Zhang M; Guidon G; Buda C; Sastre JP; Feng JQ; Franco P; Brown SH; Upton N; Medhurst AD; Lin JS
    Br J Pharmacol; 2009 May; 157(1):104-17. PubMed ID: 19413575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic role in stimulant-induced wakefulness.
    Wisor JP; Nishino S; Sora I; Uhl GH; Mignot E; Edgar DM
    J Neurosci; 2001 Mar; 21(5):1787-94. PubMed ID: 11222668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.
    Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE
    Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
    Edgar DM; Seidel WF
    J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
    Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
    Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset.
    Sato M; Sagawa Y; Hirai N; Sato S; Okuro M; Kumar S; Kanbayashi T; Shimizu T; Sakai N; Nishino S
    Exp Neurol; 2014 Nov; 261():744-51. PubMed ID: 25118620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy.
    Zhang S; Zeitzer JM; Sakurai T; Nishino S; Mignot E
    J Physiol; 2007 Jun; 581(Pt 2):649-63. PubMed ID: 17379635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Astroglial Connexins on Modafinil Pharmacological Properties.
    Duchêne A; Perier M; Zhao Y; Liu X; Thomasson J; Chauveau F; Piérard C; Lagarde D; Picoli C; Jeanson T; Mouthon F; Dauvilliers Y; Giaume C; Lin JS; Charvériat M
    Sleep; 2016 Jun; 39(6):1283-92. PubMed ID: 27091533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.
    Orrú M; Guitart X; Karcz-Kubicha M; Solinas M; Justinova Z; Barodia SK; Zanoveli J; Cortes A; Lluis C; Casado V; Moeller FG; Ferré S
    Neuropharmacology; 2013 Apr; 67():476-84. PubMed ID: 23261866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
    Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
    Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat.
    Wisor JP; Dement WC; Aimone L; Williams M; Bozyczko-Coyne D
    Pharmacol Biochem Behav; 2006 Nov; 85(3):492-9. PubMed ID: 17134745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
    Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
    Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil.
    Wisor JP; Eriksson KS
    Neuroscience; 2005; 132(4):1027-34. PubMed ID: 15857707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
    Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Casas M; Ungerstedt U; Andén NE
    Eur J Pharmacol; 1991 Jan; 192(1):31-7. PubMed ID: 1828237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of caffeine and modafinil in counteracting sleep deprivation in the marmoset monkey.
    van Vliet SA; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Psychopharmacology (Berl); 2008 Mar; 197(1):59-66. PubMed ID: 18057918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep.
    Zeitzer JM; Buckmaster CL; Landolt HP; Lyons DM; Mignot E
    Behav Pharmacol; 2009 Oct; 20(7):643-52. PubMed ID: 19752724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.